VENLAFAXINE HYDROCHLORIDE (venlafaxine hydrochloride) by Teva is cns. Approved for major depressive disorder (mdd), social anxiety disorder (sad), known and 1 more indications. First approved in 2006.
Drug data last refreshed 21h ago
CNS. Preclinical studies have shown that venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak inhibitors of dopamine reuptake.
Worked on VENLAFAXINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions